Apriem Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.94M | Buy |
12,045
+162
| +1% | +$37.7K | 0.28% | 56 |
|
|
2025
Q4 | $2.46M | Sell |
11,883
-27
| -0.2% | -$5.34K | 0.23% | 62 |
|
|
2025
Q3 | $2.21M | Buy |
11,910
+27
| +0.2% | +$4.63K | 0.21% | 64 |
|
|
2025
Q2 | $1.82M | Sell |
11,883
-141
| -1% | -$21.7K | 0.19% | 67 |
|
|
2025
Q1 | $1.99M | Sell |
12,024
-191
| -2% | -$29.9K | 0.23% | 60 |
|
|
2024
Q4 | $1.77M | Sell |
12,215
-225
| -2% | -$34.9K | 0.2% | 62 |
|
|
2024
Q3 | $2.02M | Sell |
12,440
-1,492
| -11% | -$238K | 0.24% | 57 |
|
|
2024
Q2 | $2.04M | Sell |
13,932
-8,364
| -38% | -$1.24M | 0.25% | 57 |
|
|
2024
Q1 | $3.53M | Sell |
22,296
-1,036
| -4% | -$165K | 0.44% | 40 |
|
|
2023
Q4 | $3.66M | Sell |
23,332
-999
| -4% | -$153K | 0.49% | 37 |
|
|
2023
Q3 | $3.79M | Sell |
24,331
-737
| -3% | -$122K | 0.56% | 35 |
|
|
2023
Q2 | $4.15M | Sell |
25,068
-271
| -1% | -$43.7K | 0.62% | 34 |
|
|
2023
Q1 | $3.93M | Buy |
25,339
+129
| +0.5% | +$20.8K | 0.63% | 34 |
|
|
2022
Q4 | $4.45M | Sell |
25,210
-67
| -0.3% | -$11.6K | 0.77% | 29 |
|
|
2022
Q3 | $4.13M | Sell |
25,277
-951
| -4% | -$161K | 0.74% | 29 |
|
|
2022
Q2 | $4.66M | Sell |
26,228
-473
| -2% | -$84.3K | 0.8% | 28 |
|
|
2022
Q1 | $4.73M | Sell |
26,701
-4,743
| -15% | -$807K | 0.69% | 31 |
|
|
2021
Q4 | $5.38M | Sell |
31,444
-16,114
| -34% | -$2.64M | 0.76% | 28 |
|
|
2021
Q3 | $7.68M | Sell |
47,558
-1,816
| -4% | -$310K | 1.1% | 23 |
|
|
2021
Q2 | $8.13M | Sell |
49,374
-3,486
| -7% | -$577K | 1.21% | 24 |
|
|
2021
Q1 | $8.69M | Sell |
52,860
-23,521
| -31% | -$3.81M | 1.35% | 24 |
|
|
2020
Q4 | $12M | Sell |
76,381
-10,432
| -12% | -$1.54M | 2.14% | 17 |
|
|
2020
Q3 | $12.9M | Sell |
86,813
-1,603
| -2% | -$237K | 2.37% | 16 |
|
|
2020
Q2 | $12.4M | Sell |
88,416
-1,307
| -1% | -$190K | 2.55% | 14 |
|
|
2020
Q1 | $11.8M | Sell |
89,723
-2,252
| -2% | -$320K | 2.85% | 8 |
|
|
2019
Q4 | $13.4M | Buy |
91,975
+9,056
| +11% | +$1.23M | 2.57% | 7 |
|
|
2019
Q3 | $10.7M | Buy |
82,919
+80,640
| +3,538% | +$10.6M | 2.38% | 9 |
|
|
2019
Q2 | $317K | Sell |
2,279
-428
| -16% | -$59.2K | 0.1% | 102 |
|
|
2019
Q1 | $378K | Sell |
2,707
-584
| -18% | -$78.2K | 0.1% | 84 |
|
|
2018
Q4 | $425K | Buy |
3,291
+196
| +6% | +$27.3K | 0.15% | 77 |
|
|
2018
Q3 | $428K | Buy |
3,095
+409
| +15% | +$54.4K | 0.09% | 92 |
|
|
2018
Q2 | $326K | Buy |
2,686
+237
| +10% | +$29.6K | 0.07% | 95 |
|
|
2018
Q1 | $314K | Sell |
2,449
-165
| -6% | -$22.3K | 0.08% | 94 |
|
|
2017
Q4 | $365K | Sell |
2,614
-200
| -7% | -$27.9K | 0.09% | 86 |
|
|
2017
Q3 | $366K | Buy |
2,814
+217
| +8% | +$28.8K | 0.09% | 93 |
|
|
2017
Q2 | $344K | Buy |
2,597
+155
| +6% | +$19.8K | 0.09% | 89 |
|
|
2017
Q1 | $304K | Sell |
2,442
-1,185
| -33% | -$142K | 0.08% | 94 |
|
|
2016
Q4 | $418K | Buy |
3,627
+770
| +27% | +$88.9K | 0.12% | 78 |
|
|
2016
Q3 | $337K | Buy |
2,857
+656
| +30% | +$79.6K | 0.1% | 85 |
|
|
2016
Q2 | $267K | Buy |
2,201
+476
| +28% | +$54.1K | 0.09% | 92 |
|
|
2016
Q1 | $187K | Buy |
1,725
+589
| +52% | +$61K | 0.07% | 99 |
|
|
2015
Q4 | $117K | Buy |
1,136
+117
| +11% | +$11.8K | 0.04% | 125 |
|
|
2015
Q3 | $95K | Sell |
1,019
-214
| -17% | -$20.7K | 0.04% | 143 |
|
|
2015
Q2 | $120K | Buy |
1,233
+264
| +27% | +$26.4K | 0.04% | 131 |
|
|
2015
Q1 | $97K | Sell |
969
-50
| -5% | -$5.08K | 0.03% | 149 |
|
|
2014
Q4 | $107K | Buy |
1,019
+1
| +0.1% | +$105 | 0.04% | 129 |
|
|
2014
Q3 | $109K | Sell |
1,018
-15,694
| -94% | -$1.63M | 0.04% | 134 |
|
|
2014
Q2 | $1.75M | Sell |
16,712
-100
| -0.6% | -$10.1K | 0.67% | 48 |
|
|
2014
Q1 | $1.65M | Sell |
16,812
-36,780
| -69% | -$3.41M | 0.62% | 51 |
|
|
2013
Q4 | $4.91M | Sell |
53,592
-29,406
| -35% | -$2.71M | 1.92% | 14 |
|
|
2013
Q3 | $7.2M | Sell |
82,998
-3,097
| -4% | -$278K | 3.12% | 4 |
|
|
2013
Q2 | $7.39M | Buy |
+86,095
| New | +$7.31M | 3.62% | 2 |
|
Other funds holding JNJ
VCM
VPM
Apriem Advisors's JNJ Position: Q1 2026 in Review
Apriem Advisors increased its Johnson & Johnson (JNJ) stake by 1.4% in Q1 2026, buying an estimated $37.7K and bringing the position to 12,045 shares worth $2.94M. The position accounts for 0.28% of the portfolio, ranked #56.
Apriem Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.4M in Q4 2019. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Apriem Advisors held 12,045 shares of Johnson & Johnson worth $2.94M as of Q1 2026.
- Apriem Advisors bought 162 Johnson & Johnson shares in Q1 2026, an estimated $37.7K.
- Johnson & Johnson made up 0.28% of Apriem Advisors's portfolio in Q1 2026, its #56 holding.
- Apriem Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
- Apriem Advisors's Johnson & Johnson position peaked at $13.4M in Q4 2019.
- 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Apriem Advisors's 13F filing for Q1 2026, filed 15 May 2026.